Takeda Pharmaceuticals
Australia announced that Nesina
(alogliptin), a new DPP-4 inhibitor,
is to be reimbursed on the PBS
from 01 Dec 2013.
Nesina is an oral medication
indicated to improve glycaemic
control in adults with Type 2
diabetes when added to other anti-diabetic
medications.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Nov 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Nov 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.